Clinuvel stock price

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Clinuvel stock price

According to TipRanks. The word on The Street in general, suggests a Moderate Buy analy E ratio of TipRanks has tracked 36, company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following thei See the top stocks Clinuvel Pharmaceuticals Ltd. It also offers drugs for the treatment of various skin disorders. This browser is no longer supported at MarketWatch. For the best MarketWatch. Market Data.

Data and content is provided for personal use only. Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Susan Smith.

February 24, James Mickleboro. Big returns could be on the cards for owners of these shares according to analysts. February 22, James Mickleboro. February 14, Bronwyn Allen. Will population changes and economic growth in the regions lead to more people buying investment properties there? And is this….

Key events shows relevant news articles on days with large price movements. Clinuvel Pharmaceuticals Limited. CUV 0. UR9 1. Chimerix Inc. CMRX 0. Ideal Power Inc.

Clinuvel stock price

Scenesse is the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called EPP and is fairly protected in the near-term from competition. Morningstar brands and products. Investing Ideas. As of Mar 8, am Delayed Price Closed. Unlock our analysis with Morningstar Investor. Start Free Trial. Mar 8,

Kazumi instagram

Still having trouble viewing content? According to TipRanks. Geographically, the company derives the majority of its revenue from its US and European markets. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities. Create Account … or Log In. Dennis J. This browser is no longer supported at MarketWatch. November 15, Bronwyn Allen. Card Details Edit. Other Dow Jones. Recently Viewed. Here are a number of small caps that the broker has given the thumbs up to this week. All content on FT. No Saved Watchlists Create a list of the investments you want to track.

.

Earnings per share 0. Call Remember me. Net Income. Symbols Loading Dr Wolgen is currently leading the Group's expansion, with an immediate focus on the US and the further development of the product pipeline for various market segments. Data Policy. Source: Kantar Media. All content on FT. View our membership page for more information. What our members say about us.